In the present study, we retrospectively investigated whether the clinicopathologic factors and the expression levels of ERCC1 in tumor tissue, measured using immunohistochemical staining, were associated with prognosis in Chinese patients who underwent surgery for p-stage III-N2 NSCLC. Here, ERCC1 is linked to non-small cell lung carcinoma.